Cargando…
Application of metastatic biopsy based on “When, Who, Why, Where, How (4W1H)” principle in diagnosis and treatment of metastatic castration-resistance prostate cancer
BACKGROUND: To determine the feasibility of secondary biopsy of metastatic castration-resistance prostate cancer based on the “4W1H—When, Who, Why, Where, How” principle and analyze the factors that affect tumor detection. Its application will further direct the patients for individualized precision...
Autores principales: | Liu, Zihao, Wang, Lei, Zhou, Yuchi, Wang, Chao, Ma, Yuan, Zhao, Yang, Tian, Jing, Huang, Hua, Wang, Haitao, Wang, Yong, Niu, Yuanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100831/ https://www.ncbi.nlm.nih.gov/pubmed/33968660 http://dx.doi.org/10.21037/tau-21-23 |
Ejemplares similares
-
The Crucial Questions on Synovial Biopsy: When, Why, Who, What, Where, and How?
por: Ingegnoli, Francesca, et al.
Publicado: (2021) -
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
por: Giraudet, Anne-Laure, et al.
Publicado: (2021) -
Collaborative Web Search: Who, What, Where, When, and Why
por: Morris, Meredith Ringel, et al.
Publicado: (2009) -
Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
por: Sandhu, Vaneet K, et al.
Publicado: (2022) -
The why, what, where, when and how of goal-directed choice: neuronal and computational principles
por: Verschure, Paul F. M. J., et al.
Publicado: (2014)